 SOUTH SAN FRANCISCO, Calif., June 01, 2021 GLOBE NEWSWIRE -- Cytokinetics, Incorporated Nasdaq: CYTK today announced that on May 31, 2021 it granted stock options to purchase an aggregate of 49,500 shares of common stock to eight new employees whose employment commenced in May 2021 as a material inducement to their employment. The grant was previously approved by the Compensation and Talent Committee of Cytokinetics Board of Directors under the companys Amended and Restated 2004 Equity Incentive Plan. 